DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🟢 Decoy Therapeutics is trading 10.2% up today after continued rebound from Ebola Zaire platform success
Decoy Therapeutics is trading at $4.44 (+10.17%) as it extends a rebound triggered by July 28 lab results for its Ebola Zaire platform. • The move appears to...
🟢 Decoy Therapeutics is trading 5.7% up today on an extended rebound from its Ebola Zaire platform success
Decoy Therapeutics is trading at $4.26 (+5.71%) in after-hours trading, extending a rebound tied to the success of its Ebola Zaire platform. • The move...
🟢 Decoy Therapeutics is trading 6.2% up today on Ebola Zaire platform success
Decoy Therapeutics is trading 6.2% up today at $4.29 as the stock extends its rebound following positive lab results for its antiviral platform against Ebola...
🔴 Decoy Therapeutics is trading 10.9% down today, giving back gains from its recent two-day rebound
Decoy Therapeutics is trading 10.9% down at $3.60, giving back part of its sharp two-day rebound following a period of high volatility. • The move follows a...
Decoy Therapeutics Proves Its Antiviral Platform Works Beyond COVID — But Can a $3 Million Company Capitalize on That Promise?
Shares of Decoy Therapeutics surged +10% to $4.12 Monday after the micro-cap biotech announced that a drug candidate originally built to fight coronaviruses...
🟢 Decoy Therapeutics is trading 10% up today after Ebola data validates D-MAV platform
Decoy Therapeutics is trading at $4.12 (+10.03%) after announcing that its D-MAV candidate showed in vitro activity against the wild-type Ebola Zaire virus. •...
🟢 Decoy Therapeutics is trading 6.4% up today as Ebola data validates D-MAV platform
Decoy Therapeutics is trading at $3.98 (up 6.4%) after announcing that a D-MAV candidate demonstrated in vitro activity against the wild-type Ebola Zaire...
Decoy Therapeutics Validates Platform, Proving In Vitro Activity Against Ebola Virus
Decoy Therapeutics Inc. reported on July 27, 2026, that a D-MAV candidate demonstrated in vitro activity against the wild-type Ebola Zaire virus. This finding...
🔴 Decoy Therapeutics is trading 6.4% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading 6.4% down at $3.50 in pre-market, extending a sharp multi-day slide that accelerated on July 27, 2026, despite a lack of...
🔴 Decoy Therapeutics is trading 20% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading at $4.03 (down 20%), extending a multi-day slide from last week with no fresh, company-specific news identified as a clear...
🔴 Decoy Therapeutics is trading 13.69% down today with no clear company-specific catalyst
Decoy Therapeutics is trading at $4.35 (-13.69%) in pre-market sessions as the stock extends a multi-day slide despite a lack of fresh fundamental news. • No...
🔴 Decoy Therapeutics is trading 5.8% down today, extending a multi-day slide with no clear catalyst
Decoy Therapeutics is trading 5.8% down at $4.75 in after-hours trading, extending a sharp multi-day slide from mid-July highs near $6. • There are no fresh...
🔴 Decoy Therapeutics is trading 6.25% down today with no clear catalyst
Decoy Therapeutics is trading 6.25% down today at $4.80 with no clear catalyst, extending a sharp multi-day slide. • Shares have declined materially from the...
🟢 Decoy Therapeutics is trading 5.1% up today despite a lack of fresh news
Decoy Therapeutics is trading 5.1% up at $5.38 today despite a lack of fresh company-specific headlines or catalysts explaining the move. • The stock's gain...
🟢 Decoy Therapeutics is trading 11.8% up
Decoy Therapeutics is trading at $5.50, up 11.8% from a comparison close of $4.92 during pre-market. This is a price-action follow-up, so a separate catalyst...
🟢 Decoy Therapeutics is trading 11.8% up today as it rebounds from post-financing weakness
Decoy Therapeutics is trading at $5.50 (up 11.8%) in after-hours sessions as it rebounds from recent weakness following its $21 million private placement...
🔴 Decoy Therapeutics is trading 6.6% down today as post-financing rally fades
Decoy Therapeutics is trading at $5.24 (-6.60%) as the stock extends its pullback following a late-June rally tied to a $21 million private placement...
🟢 Decoy Therapeutics is trading 5.7% up today as it rebounds from a recent pullback following its $21 million financing
Decoy Therapeutics is trading at $5.93 (+5.7%) in pre-market, staging a modest recovery after a 6.3% pullback on July 17. • The stock's recent volatility...
🟢 Decoy Therapeutics is trading 7% up today as it rebounds from a recent pullback amid sector volatility
Decoy Therapeutics is trading at approximately $6.00 (7% up) in after-hours trading, staging a rebound following a sharp pullback in recent days despite...
🔴 Decoy Therapeutics is trading 5.5% down today amid biotech volatility and broader risk-off sentiment
Decoy Therapeutics is trading 5.5% down at $5.66 today, extending a recent pullback amid ongoing volatility in speculative micro-cap biotech names and a...